Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 severity is predicted by earlier evidence of accelerated aging.
Kuo CL, Pilling LC, Atkins JL, Masoli JA, Delgado J, Tignanelli C, Kuchel GA, Melzer D, Beckman KB, Levine ME. Kuo CL, et al. Among authors: beckman kb. medRxiv [Preprint]. 2020 Jul 11:2020.07.10.20147777. doi: 10.1101/2020.07.10.20147777. medRxiv. 2020. PMID: 32676624 Free PMC article. Preprint.
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19.
Puskarich MA, Cummins NW, Ingraham NE, Wacker DA, Reilkoff RA, Driver BE, Biros MH, Bellolio F, Chipman JG, Nelson AC, Beckman K, Langlois R, Bold T, Aliota MT, Schacker TW, Voelker HT, Murray TA, Koopmeiners JS, Tignanelli CJ. Puskarich MA, et al. EClinicalMedicine. 2021 Jun 17;37:100957. doi: 10.1016/j.eclinm.2021.100957. eCollection 2021 Jul. EClinicalMedicine. 2021. PMID: 34195577 Free PMC article.
Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial.
Puskarich MA, Ingraham NE, Merck LH, Driver BE, Wacker DA, Black LP, Jones AE, Fletcher CV, South AM, Murray TA, Lewandowski C, Farhat J, Benoit JL, Biros MH, Cherabuddi K, Chipman JG, Schacker TW, Guirgis FW, Voelker HT, Koopmeiners JS, Tignanelli CJ; Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators. Puskarich MA, et al. JAMA Netw Open. 2022 Mar 1;5(3):e222735. doi: 10.1001/jamanetworkopen.2022.2735. JAMA Netw Open. 2022. PMID: 35294537 Free PMC article. Clinical Trial.
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA; COVID-OUT Trial Team. Bramante CT, et al. N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662. N Engl J Med. 2022. PMID: 36070710 Free PMC article. Clinical Trial.
Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.
Johnson AJ, Zhou S, Hoops SL, Hillmann B, Schomaker M, Kincaid R, Daniel J, Beckman K, Gohl DM, Yohe S, Knights D, Nelson AC. Johnson AJ, et al. Microbiol Spectr. 2021 Sep 3;9(1):e0008621. doi: 10.1128/Spectrum.00086-21. Epub 2021 Jul 14. Microbiol Spectr. 2021. PMID: 34259552 Free PMC article.
88 results